Inhibition of atherogenesis in LDLR knockout mice by systemic delivery of adeno-associated virus type 2-hIL-10

Atherosclerosis

Volumn 188, Issue 1, 2006, Pages 19-27

  Liu, Yong ^a   Li, Dayuan ^a   Chen, Jiawei ^a   Xie, Jin ^a   Bandyopadhyay, Sarmistha ^a   Zhang, Dazhi ^a,b   Nemarkommula, Aravind R ^a   Liu, Hongmei ^a   Mehta, Jawahar L ^a   Hermonat, Paul L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Adeno associated virus; Atherosclerosis; Gene therapy; Granulocyte macrophage colony stimulating factor; Inflammation; Interleukin 10; Systemic delivery

Indexed keywords

3 NITROTYROSINE; APOLIPOPROTEIN E; CD68 ANTIGEN; LOW DENSITY LIPOPROTEIN RECEPTOR; PARVOVIRUS VECTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; ATHEROGENESIS; CHOLESTEROL DIET; CONTROLLED STUDY; CYTOKINE RELEASE; DATA ANALYSIS; GENE TRANSFER; HYPERLIPOPROTEINEMIA TYPE 3; INFLAMMATION; LIPID BLOOD LEVEL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; AORTA; ATHEROSCLEROSIS; CHOLESTEROL, DIETARY; DEPENDOVIRUS; DNA; GENE THERAPY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-10; MICE; MICE, KNOCKOUT; RECEPTORS, LDL; RNA, MESSENGER;

EID: 33746700195     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.10.029     Document Type: Article

References (49)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
2. Minor Jr. R.L., Myers P.R., Guerra Jr. R., Bates J.N., and Harrison D.G. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest 86 (1990) 2109-2116
3. Chen J., and Mehta J.L. Role of oxidative stress in coronary heart disease. Indian Heart J 56 (2004) 163-173
4. Lawson D.L., Mehta J.L., Nichols W.W., Mehta P., and Donnelly W.H. Superoxide radical-mediated endothelial injury and vasoconstriction of rat thoracic aortic rings. J Lab Clin Med 115 (1990) 541-548
5. Rubanyi G.M., and Vanhoutte P.M. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 250 (1986) H822-H827
6. Witztum J.L., and Steinberg D. The oxidative modification hypothesis of atherosclerosis: does it hold for humans?. Trends Cardiovasc Med 11 (2001) 93-102
7. Petrone W.F., English D.K., Wong K., and McCord J.M. Free radicals and inflammation: superoxide-dependent activation of a neutrophil chemotactic factor in plasma. Proc Natl Acad Sci USA 77 (1980) 1159-1163
8. Girndt M., and Kohler H. Interleukin-10 (IL-10): an update on its relevance for cardiovascular risk. Nephrol Dial Transplant 18 (2003) 1976-1979
9. Ralph P., Nakoinz I., Sampson-Johannes A., et al. IL-10 T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol 148 (1992) 808-814
10. Cassatella M.A., Meda L., Bonora S., Ceska M., and Constantin G. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 178 (1993) 2207-2211
11. Joss A., Akdis M., Faith A., Blaser K., and Akdis C.A. IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway. Eur J Immunol 30 (2000) 1683-1690
12. Akdis C.A., Joss A., Akdis M., and Blaser K. Mechanism of IL-10-induced T cell inactivation in allergic inflammation and normal response to allergens. Int Arch Allergy Immunol 124 (2001) 180-182
13. Imperiale M.J., and Kochanek S. Adenovirus vectors: biology, design, and production. Curr Top Microbiol Immunol 273 (2004) 335-357
14. Cao H., Koehler D.R., and Hu J. Adenoviral vectors for gene replacement therapy. Viral Immunol 17 (2004) 327-333
15. Barquinero J., Eixarch H., and Perez-Melgosa M. Retroviral vectors: new applications for an old tool. Gene Ther 11 Suppl. 1 (2004) S3-S9
16. Gallo R.C. Human retroviruses after 20 years: a perspective from the past and prospects for their future control. Immunol Rev 185 (2002) 236-265
17. Hermonat P.L., and Muzyczka N. Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci USA 81 (1984) 6466-6470
18. Tratschin J.D., West M.H., Sandbank T., and Carter B.J. A human parvovirus, adeno-associated virus, as a eucaryotic vector: transient expression and encapsidation of the procaryotic gene for chloramphenicol acetyltransferase. Mol Cell Biol 4 (1984) 2072-2081
19. Xiao X., Li J., and Samulski R.J. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol 70 (1996) 8098-8108
20. Hermonat P.L. The adeno-associated virus Rep78 gene inhibits cellular transformation induced by bovine papillomavirus. Virology 172 (1989) 253-261
21. Hermonat P.L. Inhibition of H-ras expression by the adeno-associated virus Rep78 transformation suppressor gene product. Cancer Res 51 (1991) 3373-3377
22. Coker A.L., Russell R.B., Bond S.M., et al. Adeno-associated virus is associated with a lower risk of high-grade cervical neoplasia. Exp Mol Pathol 70 (2001) 83-89
23. Smith J., Herrero R., Erles K., et al. Adeno-associated virus seropositivity and HPV-induced cervical cancer in Spain and Colombia. Int J Cancer 94 (2001) 520-526
24. Mayor H.D., Drake S., Stahmann J., and Mumford D.M. Antibodies to adeno-associated satellite virus and herpes simplex in sera from cancer patients and normal adults. Am J Obstet Gynecol 126 (1976) 100-104
25. Walz C.M., Nakamura M., Fukunaga T., et al. Reduced prevalence of serum antibodies against adeno-associated virus type 2 in patients with adult T-cell leukaemia lymphoma. J Med Virol 65 (2001) 185-189
26. Welch C.L., Bretschger S., Latib N., et al. Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model. Proc Natl Acad Sci USA 98 (2001) 7946-7951
27. Liu L., Hu H., Ji H., et al. Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR knockout mouse model within six months. Mol Cell Biochem 215 (2000) 123-128
28. Azzawi M., Kan S.W., Hillier V., et al. The distribution of cardiac macrophages in myocardial ischaemia and cardiomyopathy. Histopathology 46 3 (2005) 314-319
29. Hayashi T., Rani P.J.A., Fukatsu A., et al. A new HMG-CoA reductase inhibitor, pitavastatin remarkably retards the progression of high cholesterol induced atherosclerosis in rabbits. Atherosclerosis 176 2 (2004) 255-263
30. Mazighi M., Pelle A., Gonzalez W., et al. IL-10 inhibits vascular smooth muscle cell activation in vitro and in vivo. Am J Physiol Heart Circ Physiol 287 (2004) H866-H871
31. Yoshioka T., Okada T., Maeda Y., et al. Adeno-associated virus vector-mediated interleukin-10 gene transfer inhibits atherosclerosis in apolipoprotein E-deficientmice. Gene Ther 11 (2004) 1772-1779
32. Zhou J.H., Broussard S.R., Strle K., et al. IL-10 inhibits apoptosis of promyeloid cells by activating insulin receptor substrate-2 and phosphatidylinositol 3′-kinase. J Immunol 167 (2001) 4436-4442
33. Krakauer T. IL-10 inhibits the adhesion of leukocytic cells to IL-1-activated human endothelial cells. Immunol Lett 45 (1995) 61-65
34. Wang P., Wu P., Siegel M.I., Egan R.W., and Billah M.M. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 270 (1995) 9558-9563
35. Chatelain R., Wollenberg A., Martin C., et al. IL-10 inhibits ICAM-1 expression on human Langerhans cells but not on keratinocytes, dermal endothelial cells orfibroblasts. Arch Dermatol Res 290 (1998) 477-482
36. Kimura B., Mohuczy D., Tang X., and Phillips M.I. Attenuation of hypertension and heart hypertrophy by adeno-associated virus delivering angiotensinogen antisense. Hypertension 37 (2001) 376-380
37. Liu Y., Santin A.D., Mane M., et al. Transduction and utility of the granulocyte macrophage-colony stimulating factor gene into dendritic cells by adeno-associated virus. J Interferon Cytokine Res 20 (2000) 21-30
38. Liu Y., Chiriva-Internati M., Grizzi F., et al. Rapid induction of cytotoxic T cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector. Cancer Gene Ther 8 (2001) 948-957
39. Vieira P., de Waal-Malefyt R., Dang M.N., et al. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci USA 88 (1991) 1172-1176
40. Chiriva-Internati M., Liu Y., Salati E., et al. Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus-human papillomavirus type 16 E7 antigen transduction into dendritic cells. Eur J Immunol 32 (2002) 30-38
41. You H., Liu Y., Carey M.J., Lowery C.L., and Hermonat P.L. Defective 3A trophoblast-endometrial cell adhesion, and altered 3A growth and survival by human papillomavirus type 16 oncogenes. Mol Cancer Res 1 (2002) 25-31
42. Chiriva-Internati M., Liu Y., Weidanz J.A., et al. Testing recombinant adeno-associated virus-gene loading of dendritic cells for generating potent cytotoxic T lymphocytes against a prototype self-antigen, multiple myeloma HM 1.24. Blood 102 (2003) 3100-3107
43. Liu Y., Chiriva-Internati M., You C., et al. Use and specificity of breast cancer antigen/milk protein BA46 for generating anti-self-cytotoxic T lymphocytes by recombinant adeno-associated virus-based gene loading of dendritic cells. Cancer Gene Ther 12 (2005) 304-312
44. Agrawal N., You H., Liu Y., et al. Generation of recombinant skin in vitro by adeno-associated virus type 2 vector transduction. Tissue Eng 10 (2004) 1707-1715
45. Auricchio A., Hildinger M., O'Connor E., Gao G.P., and Wilson J.M. Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum Gene Ther 12 (2001) 71-76
46. Pisa P., Halapi E., Pisa E.K., et al. Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage-colony stimulating factor in ovarian cancer biopsies. Proc Natl Acad Sci USA 89 (1992) 7708-7712
47. Li D., Williams V., Liu L., et al. Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction. J Am Coll Cardiol 41 (2003) 1048-1055
48. Chobanian A.V., Lichtenstein A.H., Nilakhe V., et al. Influence of hypertension on aortic atherosclerosis in the Watanabe rabbit. Hypertension 14 (1989) 203-209
49. Palinski W., Ord V.A., Plump A.S., et al. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb 14 (1994) 605-616